-
ICD-10-CM Codes
›
-
Z00-Z99
Factors influencing health status and contact with health services
›
-
Z14-Z15
Genetic carrier and genetic susceptibility to disease
›
-
Z15-
Genetic susceptibility to disease
›
-
2021 ICD-10-CM Diagnosis Code Z15.81
2021 ICD-10-CM Diagnosis Code Z15.81
Genetic susceptibility to multiple endocrine neoplasia [MEN]
2016 2017 2018 2019 2020 2021 Billable/Specific Code POA Exempt
- Z15.81 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2021 edition of ICD-10-CM Z15.81 became effective on October 1, 2020.
- This is the American ICD-10-CM version of Z15.81 - other international versions of ICD-10 Z15.81 may differ.
Type 1 ExcludesType 1 Excludes Help
A type 1 excludes note is a pure excludes. It means "not coded here". A type 1 excludes note indicates that the code excluded should never be used at the same time as Z15.81. A type 1 excludes note is for used for when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
The following code(s) above
Z15.81 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
- Applicable To annotations, or
- Code Also annotations, or
- Code First annotations, or
- Excludes1 annotations, or
- Excludes2 annotations, or
- Includes annotations, or
- Note annotations, or
- Use Additional annotations
that may be applicable to
Z15.81:
Approximate Synonyms
- Genetic susceptibility to multiple endocrine neoplasia
Present On AdmissionPOA Help
"Present On Admission" is defined as present at the time the order for inpatient admission occurs — conditions that develop during an outpatient encounter, including emergency department, observation, or outpatient surgery, are considered POA.
- Z15.81 is considered exempt from POA reporting.
ICD-10-CM Z15.81 is grouped within Diagnostic Related Group(s) (MS-DRG v38.0):
- 951 Other factors influencing health status
Convert Z15.81 to ICD-9-CM
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- Genetic
- susceptibility to disease NEC Z15.89
ICD-10-CM Diagnosis Code Z15.89
Genetic susceptibility to other disease
2016 2017 2018 2019 2020 2021 Billable/Specific Code POA Exempt
- multiple endocrine neoplasia Z15.81
- Susceptibility to disease, genetic Z15.89
ICD-10-CM Diagnosis Code Z15.89
Genetic susceptibility to other disease
2016 2017 2018 2019 2020 2021 Billable/Specific Code POA Exempt
- multiple endocrine neoplasia Z15.81
ICD-10-CM Codes Adjacent To Z15.81
Z14.1 Cystic fibrosis carrier
Z14.8 Genetic carrier of other disease
Z15 Genetic susceptibility to disease
Z15.0 Genetic susceptibility to malignant neoplasm
Z15.09 Genetic susceptibility to other malignant neoplasm
Z15.8 Genetic susceptibility to other disease
Z15.81
Genetic susceptibility to multiple endocrine neoplasia [MEN]
Z15.89 Genetic susceptibility to other disease
Z16 Resistance to antimicrobial drugs
Z16.1 Resistance to beta lactam antibiotics
Z16.10 Resistance to unspecified beta lactam antibiotics
Z16.11 Resistance to penicillins
Z16.12 Extended spectrum beta lactamase (ESBL) resistance
Z16.19 Resistance to other specified beta lactam antibiotics
Z16.2 Resistance to other antibiotics
Z16.20 Resistance to unspecified antibiotic
Z16.21 Resistance to vancomycin
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.